April 5, 2022
A key Japanese panel will discuss whether to recommend approval for Novavax’s COVID-19 vaccine NVX-CoV2373/TAK-019, which was filed by local partner Takeda Pharmaceutical, at its meeting on April 18. In Japan, Takeda is responsible for the domestic production and distribution...read more